| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 28 |
| 1 | PREDNISONE | 10 |
| 2 | RISANKIZUMAB-RZAA | 10 |
| 3 | CLOZAPINE | 8 |
| 4 | ERGOCALCIFEROL | 8 |
| 5 | PANTOPRAZOLE SODIUM | 8 |
| 6 | ASPIRIN | 7 |
| 7 | ASPIRIN 325 MG | 7 |
| 8 | ASPIRIN 81 MG | 7 |
| 9 | OXALIPLATIN | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MECASERMIN | 3 | 0.0037 |
| 1 | ACETAZOLAMIDE SODIUM | 6 | 0.0010 |
| 2 | SILODOSIN | 3 | 0.0007 |
| 3 | BUFFERED ASPIRIN | 1 | 0.0007 |
| 4 | SELEGILINE | 2 | 0.0007 |
| 5 | CARMUSTINE | 3 | 0.0006 |
| 6 | ZONISAMIDE | 5 | 0.0005 |
| 7 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 1 | 0.0004 |
| 8 | PANITUMUMAB | 5 | 0.0003 |
| 9 | TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM | 2 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 22 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 18 |
| 2 | Platinum-based Drug [EPC] | 14 |
| 3 | Benzodiazepine [EPC] | 12 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 12 |
| 5 | Atypical Antipsychotic [EPC] | 10 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 10 |
| 7 | Anti-epileptic Agent [EPC] | 8 |
| 8 | Mood Stabilizer [EPC] | 8 |
| 9 | Proton Pump Inhibitor [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Monoamine Oxidase Inhibitor [EPC] | 2 | 0.0006 |
| 1 | Carbonic Anhydrase Inhibitor [EPC] | 6 | 0.0003 |
| 2 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 3 | Epidermal Growth Factor Receptor Antagonist [EPC] | 6 | 0.0001 |
| 4 | Aluminum Complex [EPC] | 3 | 0.0001 |
| 5 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 3 | 0.0001 |
| 6 | Aromatic Amino Acid [EPC] | 5 | 0.0001 |
| 7 | Integrin Receptor Antagonist [EPC] | 7 | 0.0001 |
| 8 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 9 | RNA Synthetase Inhibitor Antibacterial [EPC] | 1 | 0.0001 |